Momenta Pharmaceuticals to Webcast Presentation at the LEERINK Partners 7th Annual Global Healthcare Conference

Momenta's picture
Printer-friendly versionPrinter-friendly version

CAMBRIDGE, Mass., Feb. 08, 2018 ( ) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at the LEERINK Partners 7th Annual Global Healthcare Conference. The presentation is scheduled for Thursday, February 15th at 10:00 a.m. ET.    

A webcast of the presentation will be available live on the “Investors” section of the company’s website located at www.momentapharma.com.  A replay of the presentation will be posted on the Momenta website approximately one hour after the event.

About Momenta
Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for autoimmune indications.

To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.

Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.

Copy this html code to your website/blog to embed this press release.

Comments

Post new comment

1 + 14 =

To prevent automated spam submissions leave this field empty.